Patient Satisfaction in Stroke Patients

Stroke Clinical Trial

— PatZuFrie  

Official title:

Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00994409
• Other study ID #: CSB-PatZuFrie
• Secondary ID: EA4/019/08
• Status: Completed
• Phase: N/A
• First received: October 13, 2009
• Last updated: November 30, 2010
• Start date: July 2008
• Est. completion date: November 2010

Study information

• Verified date: November 2010
• Source: Charite University, Berlin, Germany
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Description:

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1200
• Est. completion date: November 2010
• Est. primary completion date: July 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all patients eligible

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Stroke

Locations

Country	Name	City	State
Germany	Dept. Neurology, Charité Campus Benjamin Franklin	Berlin

Sponsors (3)

Lead Sponsor	Collaborator
Charite University, Berlin, Germany	Center for Stroke Research Berlin, German Federal Ministry of Education and Research

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.		September 2010	No
Secondary	Compliance/adherence with discharge medication Activities of daily living		September 2010	No
Secondary	Re-events		September 2010	No
Secondary	Degree of Disability		September 2010	No
Secondary	Mortality		September 2010	No

External Links

•   Link